These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
499 related articles for article (PubMed ID: 24493493)
21. 2007 Guideline update for unstable angina/non-ST-segment elevation myocardial infarction: focus on antiplatelet and anticoagulant therapies. Coons JC; Battistone S Ann Pharmacother; 2008 Jul; 42(7):989-1001. PubMed ID: 18577763 [TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease. Basra SS; Tsai P; Lakkis NM J Am Coll Cardiol; 2011 Nov; 58(22):2263-9. PubMed ID: 22093501 [TBL] [Abstract][Full Text] [Related]
23. [New oral anticoagulant agents: the quandary of anticoagulation in the elderly]. Páramo JA Med Clin (Barc); 2013 Oct; 141(8):346-8. PubMed ID: 23831406 [No Abstract] [Full Text] [Related]
24. [New anticoagulants: dabigatran, rivaroxaban and apixaban]. Vargas Ruiz AG; Ramírez López AN; Medina Viramontes ME Gac Med Mex; 2012; 148(3):257-64. PubMed ID: 22820359 [TBL] [Abstract][Full Text] [Related]
26. New oral anticoagulants for the treatment of venous thromboembolism. Agnelli G; Becattini C; Franco L Best Pract Res Clin Haematol; 2013 Jun; 26(2):151-61. PubMed ID: 23953903 [TBL] [Abstract][Full Text] [Related]
27. Novel oral anticoagulation in management of venous thromboembolism, atrial fibrillation, and acute coronary syndrome. Khemasuwan D; Suramaethakul N Clin Appl Thromb Hemost; 2012 Sep; 18(5):476-86. PubMed ID: 22387584 [TBL] [Abstract][Full Text] [Related]
28. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions. Cheng JW; Barillari G J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983 [TBL] [Abstract][Full Text] [Related]
29. New oral anticoagulants vs. warfarin treatment: no need for pharmacogenomics? Baker WL; Chamberlin KW Clin Pharmacol Ther; 2014 Jul; 96(1):17-9. PubMed ID: 24942397 [TBL] [Abstract][Full Text] [Related]
30. Improving adjunctive pharmacotherapy for primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: beyond the HORIZONS-AMI trial. Kereiakes DJ Rev Cardiovasc Med; 2009; 10(2):72-82. PubMed ID: 19593319 [TBL] [Abstract][Full Text] [Related]
31. Disadvantages of VKA and requirements for novel anticoagulants. Shameem R; Ansell J Best Pract Res Clin Haematol; 2013 Jun; 26(2):103-14. PubMed ID: 23953899 [TBL] [Abstract][Full Text] [Related]